Cardiovascular effects of the addition of nilotinib to standard therapy for acute myeloid leukemia

e18505Background: Angina, arrhythmias and QT prolongation have been cardiac adverse effects reported in clinical trials with nilotinib, which inhibits the tyrosine kinase activity of BCR-ABL and KI...